JOURNEY COLAB
Journey Colab pursuing FDA approval of psychedelic therapies to heal individual mental health and strengthen communities. Their first compound in development is mescaline. It was founded in 2020 and is based in San Francisco, California.
JOURNEY COLAB
Industry:
Health Care Pharmaceutical Wellness
Founded:
2020-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.journeycolab.com
Total Employee:
1+
Status:
Active
Contact:
(415) 295-5720
Email Addresses:
[email protected]
Total Funding:
15.71 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
LivWell Enlightened Health
LivWell Enlightened Health is a medical cannabis company producing and retailing multi-state cannabis.
Numinus
Numinus utilizes psychedelic-assisted psychotherapy methods to bring holistic healthcare to patients.
Sasta Sundar
Buy Genuine prescription medicine online & save big with free home delivery. India's fastest growing & most trusted Online Pharmacy.
Current Employees Featured
Founder
Investors List
Delphi VC
Delphi VC investment in Venture Round - Journey Colab
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-19 | Journey Colab Announces Appointment of Joel A. Posener, MD as Chief Medical Officer |
Official Site Inspections
http://www.journeycolab.com Semrush global rank: 4.8 M Semrush visits lastest month: 1.91 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Journey Colab"
Reciprocity - Journey Colab
The Journey Reciprocity Trust holds ten percent of the Company's founding equity and is designated to share success with community stakeholders, including Indigenous communities, to increase equitable access to care and recruit …See details»
Journey Colab - Crunchbase Company Profile & Funding
Organization. Journey Colab . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number (415) 295-5720; Journey Colab …See details»
Team - Journey Colab
Meet the team. Rebecca Lee Whiting, JD, a graduate of Yale College and the UC Berkeley School of Law, is an attorney who has represented and advised progressive organizations and public entities in strategic social change …See details»
Journey Colab - LinkedIn
Journey Colab | 1,097 followers on LinkedIn. We are on a mission to develop FDA-approved, psychedelic therapies, starting with synthetic mescaline. | Journey Colab is unlocking the science of ...See details»
Journey Colab Company Profile 2024: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Journey Colab. Use the PitchBook Platform to explore the full profile.See details»
Journey Colab - Psychedelic Science Review
Journey Colab. Journey Colab is a psychedelic pharmaceutical company founded in 2020 by current CEO Dr. Jeeshan Chowdhury and COO Jennifer Pisansky.Journey’s mission …See details»
Journey Colab - Overview, News & Similar companies - ZoomInfo
Feb 25, 2022 www.journeycolab.com. Revenue <$5 Million. Industry Pharmaceuticals Healthcare . Recent News & Media. ChatGPT creator Sam Altman has invested in dozens of …See details»
Journey Colab: Contact Details and Business Profile
Journeycolab.com; 2 310991XXXX; 310393XXXX; Lena Trbojevic Executive Assistant at Journey Colab Los Angeles, CA, US View. 2 gmail.com; journeycolab.com; 2 631428XXXX; …See details»
Journey Colab - Blossom Profile
Journey Colab aims to develop a portfolio of psychedelic compounds for use in therapy, the first of which is (synthetic) mescaline. The company puts a strong focus on collaborating with non …See details»
Journey Colab scores $12M to move psychedelics …
Sep 7, 2021 Psychedelics-focused biotech Journey Colab bagged $12 million to start its first human trial in 2022. The funding will push its lead program, a treatment based on a hallucinogenic compound found ...See details»
Contact - Journey Colab
Reach out if you want to collaborateSee details»
Journey Colab - VentureRadar
Website: https://www.journeycolab.com/ Developing psychedelic therapies for mental health. They plan to build a portfolio of plant-identical compounds with the first ...See details»
Journey Colab Raises $3 Million for Mescaline Therapy
Oct 27, 2020 Journey Colab, a platform developing a pipeline for psychedelic therapy, has announced $3 million in funding. The funding comes from Apollo Project, founded by Sam …See details»
Journey Colab secures $12M Series A funding for Phase 1 trial of ...
Sep 8, 2021 Journey Colab Corp., a privately-held psychedelic pharmaceutical startup initially funded by Sam Altman and Apollo Projects, has raised $12M in new equity funding to develop …See details»
Journey Colab: Including Traditional Communities in the Plant …
Jan 15, 2021 I am really an indigenous health advocate. I’m the executive director and founder of the Urban Indigenous Collective, which is a 501c3 grassroots organization here in New York …See details»
Mental Health Startup Journey Colab Aims To Develop Mescaline …
Apr 26, 2022 Journey Colab will test mescaline, a long-acting psychedelic found in peyote, as an adjuvant to conventional treatments for alcohol use disorder. It gives co-founder equity to the …See details»
Careers - Journey Colab
We have an integrated view of health (mind, body, and community), and provide a holistic, competitive benefit packages that includes medical, dental, vision, and life insurance, …See details»
News - Journey Colab
Journey Colab in the news. STAT First Opinion: Working with Indigenous allies is the ethical way to develop psychedelic-based pharmaceuticalsSee details»
Our research - Journey Colab
JOUR-5700 (Mescaline HCl) is a classic serotonergic psychedelic that binds and activates the serotonin 2a (5-HT2a receptor) in key cortical and subcortical structures associated with …See details»